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Background
Non-invasive imaging methods cannot reliably differenti-
ate reliably between coronary microvascular dysfunction
(CMD) and multi-vessel coronary artery disease (including
left main coronary artery disease; CAD) as both these con-
ditions may result in diffuse myocardial ischemia, which
on visual and quantitative analysis can have a similar
appearance. Consequently, patients are subjected to inva-
sive angiography, and coronary microvascular dysfunction
is diagnosed after demonstrating normal coronary arteries
in patients with myocardial ischemia. We hypothesized
that the spatial and temporal distribution of the first-pass
perfusion of the left ventricular myocardium is fundamen-
tally different between these conditions. The aim of this
study was to evaluate the spatial and temporal distribution
of perfusion (perfusion dephasing analysis) to differentiate
CMD and multivessel CAD.
Methods
This study included a total of 52 patients. All subjects
underwent adenosine-stress first-pass perfusion CMR.
Patients with a visually positive perfusion cardiac magnetic
resonance (CMR) and functional multivessel disease (frac-
tional flow reserve (FFR) ≤0.8 in at least 2 vessels; n = 25)
or a visually positive perfusion CMR and angiographically
smooth coronary arteries (CMD Group; n = 27) were
included. The datasets were analysed visually, quantified
with Fermi deconvolution and assessed for perfusion
dephasing (coefficient of variation of the time to peak of
the myocardial signal intensity curve).
Results
Visual and quantitative analysis allowed a reliable diagno-
sis of significant CAD, but could not distinguish patients
with multivessel CAD from patients with CMD as the
total extent and severity of ischemia was similar between
the two groups. In patients with CAD, perfusion analysis
showed significant dephasing proportional to the extent
and severity of the epicardial stenoses (average perfusion
dephasing in the multivessel CAD group 17% ± 8%).
In contrast, in patients with CMD there was very little per-
fusion dephasing (7% ± 2%;p < 0.001). The best threshold
to diagnose non-invasively coronary multivessel disease in
presence of diffuse left ventricular ischemia was a perfu-
sion dephasing > 10.1% (p < 0.001; area under the ROC
curve = 0.96).
Conclusions
In conclusion, perfusion-dephasing analysis, a novel
method to measure temporal differences of myocardial
perfusion, is highly accurate in distinguishing patients
with functionally significant multivessel CAD from
patients with CMD.
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